Loading...
Loading...
NEW YORK, NY · CIK 0001559706
Portfolio Value
$1.51B
Positions
29
New
8
Increased
8
Decreased
6
Sold Out
9
Slate Path Capital LP (NEW YORK, NY) reported a portfolio value of $1.51B across 29 positions in their Q3 2019 SEC 13F filing (period ending 2019-09-30). The top 10 positions account for 89.9% of the portfolio.
Top 29 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | SNAPSNAP INC | $229.89M | 15.22% | -24.1% |
| 2 | CHTRCHARTER COMMUNICATIONS INC N | $193.28M | 12.80% | -8.6% |
| 3 | MDCOUSDMEDICINES CO | $184.75M | 12.23% | +4.2% |
| 4 | ABXBARRICK GOLD CORPORATION | $169.75M | 11.24% | -21.1% |
| 5 | NYTNEW YORK TIMES CO | $144.82M | 9.59% | +34.2% |
| 6 | KEXKIRBY CORP | $112.15M | 7.43% | - |
| 7 | GEGENERAL ELECTRIC CO | $92.53M | 6.13% | - |
| 8 | ZZILLOW GROUP INC | $87.22M | 5.78% | +9.8% |
| 9 | MOSMOSAIC CO NEW | $86.72M | 5.74% | +43.1% |
| 10 | PAASPAN AMERICAN SILVER CORP | $56.45M | 3.74% | +74.8% |
| Stock | Value | Shares |
|---|---|---|
| INTELSAT S A | $25.08M | 1,100,000 |
| RETAEURREATA PHARMACEUTICALS INC | $9.63M | 120,000 |
| CUE1EURCUE BIOPHARMA INC | $7.50M | 890,000 |
| BLUE APRON HLDGS INC | $2.70M | 320,000 |
| LXLEXINFINTECH HLDGS LTD | $2.26M | 225,000 |
| PDDPINDUODUO INC | $2.09M | 65,000 |
| FCXFREEPORT-MCMORAN INC | $1.77M | 185,000 |
| MDREURMCDERMOTT INTL INC | $586.00K | 290,000 |
Get alerts when Slate Path Capital LP files new 13F holdings.